- Corporate Officers - C
- Clarke John K
Insider Trading History of Clarke John K
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Clarke John K since 2006.
This trader's CIK number is 1219015.
At the time of last reporting, Clarke John K was the Director of Atyr Pharma Inc. (stock ticker symbol LIFE).
Also see all insider trading activities at Atyr Pharma Inc.
Note that in the past
CLARKE JOHN K also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Momenta Pharmaceuticals Inc (MNTA) by Clarke John K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | MNTA | 0 | $0 | 38,400 | $766,464 | 38,400 | $400,896 |
Yearly summary of insider trading at Visicu Inc (EICU) by Clarke John K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | EICU | 0 | $0 | 418,500 | $4,201,865 | 0 | $0 |
Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Clarke John K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ALNY | 0 | $0 | 15,000 | $1,511,430 | 15,000 | $409,200 |
| 2014 | ALNY | 0 | $0 | 35,000 | $1,914,745 | 35,000 | $440,195 |
Yearly summary of insider trading at Atyr Pharma Inc (LIFE) by Clarke John K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | LIFE | 0 | $0 | 2,500 | $10,850 | 0 | $0 |
| 2020 | LIFE | 0 | $0 | 15,000 | $61,212 | 0 | $0 |
Yearly summary of insider trading at Verastem, Inc. (VSTM) by Clarke John K
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | VSTM | 88,802 | $846,375 | 0 | $0 | 0 | $0 |
| 2012 | VSTM | 256,193 | $2,548,738 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Clarke John K:
1. Momenta Pharmaceuticals Inc (MNTA)
2. Visicu Inc (EICU)
3. Alnylam Pharmaceuticals, Inc. (ALNY)
4. Atyr Pharma Inc (LIFE)
5. Verastem, Inc. (VSTM)
Table 1. Insider trading of Momenta Pharmaceuticals Inc (MNTA) by Clarke John K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-05-12 | MNTA | Option Ex | 38,400 | 10.44 | 400,896 |
| 2015-05-12 | MNTA | Sale | 38,400 | 19.96 | 766,464 |
Table 2. Insider trading of Visicu Inc (EICU) by Clarke John K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-11-30 | EICU | Sale | 387,000 | 10.04 | 3,885,479 |
| 2006-11-16 | EICU | Sale | 31,500 | 10.04 | 316,386 |
Table 3. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Clarke John K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-31 | ALNY | Sale | 15,000 | 100.76 | 1,511,430 |
| 2018-05-31 | ALNY | Option Ex | 15,000 | 27.28 | 409,200 |
| 2014-05-21 | ALNY | Option Ex | 35,000 | 12.58 | 440,195 |
| 2014-05-21 | ALNY | Sale | 35,000 | 54.71 | 1,914,745 |
Table 4. Insider trading of Atyr Pharma Inc (LIFE) by Clarke John K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-05-21 | LIFE | Sale | 2,500 | 4.34 | 10,850 |
| 2020-08-28 | LIFE | Sale | 100 | 4.00 | 400 |
| 2020-09-02 | LIFE | Sale | 7,260 | 4.01 | 29,112 |
| 2020-08-27 | LIFE | Sale | 5,440 | 4.09 | 22,249 |
| 2020-08-26 | LIFE | Sale | 2,200 | 4.30 | 9,451 |
Table 5. Insider trading of Verastem, Inc. (VSTM) by Clarke John K
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-06-12 | VSTM | Buy | 23,171 | 9.60 | 222,418 |
| 2013-06-11 | VSTM | Buy | 25,000 | 9.22 | 230,474 |
| 2013-05-13 | VSTM | Buy | 25,000 | 9.73 | 243,375 |
| 2013-05-01 | VSTM | Buy | 10,000 | 9.66 | 96,620 |
| 2013-04-17 | VSTM | Buy | 5,631 | 9.50 | 53,488 |
| 2012-12-18 | VSTM | Buy | 6,193 | 7.87 | 48,738 |
| 2012-02-01 | VSTM | Buy | 250,000 | 10.00 | 2,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Clarke John K
(Director of Atyr Pharma Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.